Cargando…
Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells
The potent and selective proteasome inhibitor bortezomib has shown remarkable antitumor activity and is now entering clinical trials for several cancers. However, the molecular mechanisms by which bortezomib induces cytotoxicity in ovarian cancer cells still remain unclear. In this study, we show th...
Autores principales: | Kao, C, Chao, A, Tsai, C L, Lin, C Y, Chuang, W C, Chen, H W, Yen, T C, Wang, T H, Lai, C H, Wang, H S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734825/ https://www.ncbi.nlm.nih.gov/pubmed/23449448 http://dx.doi.org/10.1038/cddis.2013.38 |
Ejemplares similares
-
Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
por: Kao, C, et al.
Publicado: (2014) -
Mutation of a Nopp140 gene dao-5 alters rDNA transcription and increases germ cell apoptosis in C. elegans
por: Lee, C-C, et al.
Publicado: (2014) -
Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis
por: Ilić, Duško, et al.
Publicado: (1998) -
Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013) -
Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling
por: Teague, T. Kent, et al.
Publicado: (2000)